Patent details

EP3177321 Title: TUMOR ANTIGEN SPECIFIC ANTIBODIES AND TLR3 STIMULATION TO ENHANCE THE PERFORMANCE OF CHECKPOINT INTERFERENCE THERAPY OF CANCER

Basic Information

Publication number:
EP3177321
PCT Application Number:
CA2015050747
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP158299107
PCT Publication Number:
WO2016019472
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TUMOR ANTIGEN SPECIFIC ANTIBODIES AND TLR3 STIMULATION TO ENHANCE THE PERFORMANCE OF CHECKPOINT INTERFERENCE THERAPY OF CANCER
French Title of Invention:
ANTICORPS SPECIFIQUE D'ANTIGENES TUMORAUX ET DE STIMULATION DE TLR3 POUR AMELIORER LA PERFORMANCE DE LA THERAPIE PAR INTERFERENCE DU POINT DE CONTRÔLE DU CANCER
German Title of Invention:
TUMORANTIGENSPEZIFISCHE ANTIKÖRPER UND TLR3-STIMULATION ZUR VERBESSERUNG DER LEISTUNG VON CHECKPOINT-INTERFERENZTHERAPIE VON KREBS
SPC Number:

Dates

Filing date:
07/08/2015
Grant date:
25/11/2020
EP Publication Date:
14/06/2017
PCT Publication Date:
11/02/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/11/2020
EP B1 Publication Date:
25/11/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/08/2021
Expiration date:
07/08/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/11/2020
 
 

Name:
Oncoquest Pharmaceuticals Inc.
Address:
670-21 Sannae-ro, Sannae-myeon, Miryang-Si, Korea (Republic) (KR)

Inventor

1

Name:
NICODEMUS, Christopher F.
Address:
United States (US)

2

Name:
MADIYALAKAN, Ragupathy
Address:
Canada (CA)

Priority

Priority Number:
201462034915 P
Priority Date:
08/08/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/39; A61K 39/395; A61P 35/00; A61P 37/02;

Publication

European Patent Bulletin

Issue number:
202048
Publication date:
25/11/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages